These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 2428694)
21. [Clinical use of antiandrogens in the female]. Moltz L; Schwartz U; Hammerstein J Gynakologe; 1980 Mar; 13(1):1-17. PubMed ID: 6299908 [TBL] [Abstract][Full Text] [Related]
22. Effects of two estroprogestins containing ethynilestradiol 30 microg and drospirenone 3 mg and ethynilestradiol 30 microg and chlormadinone 2 mg on skin and hormonal hyperandrogenic manifestations. Lello S; Primavera G; Colonna L; Vittori G; Guardianelli F; Sorge R; Raskovic D Gynecol Endocrinol; 2008 Dec; 24(12):718-23. PubMed ID: 19172543 [TBL] [Abstract][Full Text] [Related]
23. [Liver function tests under the influence of sequential treatment using ethinyl estradiol-norethisterone acetate and ethinyl estradiol-chlormadinone acetate]. Akpowowo HE; Göretzlehner G; Brügmann E; Töwe J Zentralbl Gynakol; 1976; 98(19):1198-203. PubMed ID: 62469 [TBL] [Abstract][Full Text] [Related]
24. Effects of an oral contraceptive containing chlormadinone and ethinylestradiol on acne-prone skin of women of different age groups: an open-label, single-centre, phase IV study. Kerscher M; Reuther T; Bayrhammer J; Schramm G Clin Drug Investig; 2008; 28(11):703-11. PubMed ID: 18840013 [TBL] [Abstract][Full Text] [Related]
25. Efficacy, safety and sustainability of treatment continuation and results of an oral contraceptive containing 30 mcg ethinyl estradiol and 2 mg chlormadinone acetate, in long-term usage (up to 45 cycles)--an open-label, prospective, noncontrolled, office-based Phase III study. Zahradnik HP; Hanjalic-Beck A Contraception; 2008 May; 77(5):337-43. PubMed ID: 18402849 [TBL] [Abstract][Full Text] [Related]
26. Treatment of hirsutism and acne in women with two combinations of cyproterone acetate and ethinylestradiol. Cremoncini C; Vignati E; Libroia A Acta Eur Fertil; 1976 Dec; 7(4):299-314. PubMed ID: 140576 [TBL] [Abstract][Full Text] [Related]
27. [Treatment of acne and seborrhea using antiandrogens]. Keller PJ; Fetz A; Schär A; Floersheim Y Schweiz Med Wochenschr; 1978 Oct; 108(42):1640-2. PubMed ID: 151916 [TBL] [Abstract][Full Text] [Related]
28. Reversed sequential therapy of hirsutism using cyproterone acetate. I. Further clinical observations. Leo-Rossberg I; Laur S; Zielske F; Hammerstein J Acta Endocrinol Suppl (Copenh); 1971; 152():14. PubMed ID: 4251533 [No Abstract] [Full Text] [Related]
29. Pituitary function and DHEA-S in male acne and DHEA-S, prolactin and cortisol before and after oral contraceptive treatment in female acne. Palatsi R; Reinilä M; Kivinén S Acta Derm Venereol; 1986; 66(3):225-30. PubMed ID: 2426899 [TBL] [Abstract][Full Text] [Related]
30. [Medium-dose oral cyproterone acetate therapy in women with moderate androgenization. Results of a multicenter double-blind study]. Moltz L; Kaiser E Geburtshilfe Frauenheilkd; 1984 Jan; 44(1):47-52. PubMed ID: 6230282 [TBL] [Abstract][Full Text] [Related]
31. [Dermatologic indications for anti-androgenic treatment]. Zaun H; Ludwig E Z Hautkr; 1978 Nov; 53(21):759-65. PubMed ID: 82309 [TBL] [Abstract][Full Text] [Related]
32. Evaluation of efficacy, safety and effects on symptoms of androgenization of a generic oral contraceptive containing chlormadinone acetate 2 mg/ethinylestradiol 0.03 mg. Hadji P; Biskup J; Boekhoff J; Ziller M; Bonn M; Rovati L Contraception; 2012 Oct; 86(4):359-65. PubMed ID: 22445436 [TBL] [Abstract][Full Text] [Related]
33. [Efficacy of oral contraceptives on acne. Apropos of a comparative study of Varnoline vs Diane in 69 women with acne]. Levrier M; Degrelle H; Bestaux Y; Bourry-Moreno M; Brun JP; Sailly F Rev Fr Gynecol Obstet; 1988; 83(7-9):573-6. PubMed ID: 2973646 [TBL] [Abstract][Full Text] [Related]
34. Cyproterone acetate/ethinyl estradiol for acne and hirsutism: time to revise prescribing policy. Franks S; Layton A; Glasier A Hum Reprod; 2008 Feb; 23(2):231-2. PubMed ID: 18083746 [TBL] [Abstract][Full Text] [Related]
35. Effects of desogestrel and gestodene in low-dose oral contraceptive combinations on lipid and lipoprotein status. A randomized prospective study. Granata A; Sobbrio GA; D'Arrigo F; Barillari M; Curasì MP; Egitto M; Trimarchi F; Granese D; Pullè C Acta Eur Fertil; 1990; 21(3):143-6. PubMed ID: 2149913 [TBL] [Abstract][Full Text] [Related]
36. Comparison of the effect on acne with a combiphasic desogestrel-containing oral contraceptive and a preparation containing cyproterone acetate. Vartiainen M; de Gezelle H; Broekmeulen CJ Eur J Contracept Reprod Health Care; 2001 Mar; 6(1):46-53. PubMed ID: 11334476 [TBL] [Abstract][Full Text] [Related]
37. The effects of desogestrel and ethinylestradiol combination in normal and hyperandrogenic young girls: speculations on contraception in adolescence. Venturoli S; Porcu E; Gammi L; Fabbri R; Paradisi R; Flamigni C; Patrono D; Capelli M; Paoletti C Acta Eur Fertil; 1988; 19(3):129-34. PubMed ID: 2976224 [TBL] [Abstract][Full Text] [Related]
38. Comparison of the clinical efficacy of flutamide and spironolactone plus ethinyloestradiol/cyproterone acetate in the treatment of hirsutism: a randomised controlled study. Karakurt F; Sahin I; Güler S; Demirbas B; Culha C; Serter R; Aral Y; Bavbek N Adv Ther; 2008 Apr; 25(4):321-8. PubMed ID: 18389188 [TBL] [Abstract][Full Text] [Related]
39. [Hormonotherapy in acute, idiopathic hirsutism, and seborrheic alopecia (author's transl)]. Belaube P; Devaux J; Gamby T; Garcin G; Privat Y Sem Hop; 1982 Jul; 58(26-27):1650-3. PubMed ID: 6287643 [TBL] [Abstract][Full Text] [Related]